US Bancorp’s Sonoma Pharmaceuticals SNOA Stock Holding History

US Bancorp’s Portfolio SNOA Stock Details SNOA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-25	Closed	-$53	–	4327
2026 Q1	$53	Hold	25	–	–	﹤0.01%	4137
2025 Q4	$91	Hold	25	–	–	﹤0.01%	4001
2025 Q3	$97	Hold	25	–	–	﹤0.01%	3966
2025 Q2	$71	Hold	25	–	–	﹤0.01%	4120
2025 Q1	$55	Hold	25	–	–	﹤0.01%	4151
2024 Q4	$67	Hold	25	–	–	﹤0.01%	4117
2024 Q3	$77	Hold	25	–	–	﹤0.01%	4039
2024 Q2	$106	Hold	25	–	–	﹤0.01%	3929
2024 Q1	$83	Hold	25	–	–	﹤0.01%	3929
2023 Q4	$90	Hold	25	–	–	﹤0.01%	3921
2023 Q3	$386	Hold	25	–	–	﹤0.01%	3878
2023 Q2	$535	Hold	25	–	–	﹤0.01%	3871
2023 Q1	$488	Hold	25	–	–	﹤0.01%	3949
2022 Q4	$560	Hold	25	–	–	﹤0.01%	3990
2022 Q3	$1K	Hold	25	–	–	﹤0.01%	4003
2022 Q2	$1K	Hold	25	–	–	﹤0.01%	4002
2022 Q1	$2K	Hold	25	–	–	﹤0.01%	3866
2021 Q4	$2K	Hold	25	–	–	﹤0.01%	3923
2021 Q3	$3K	Hold	25	–	–	﹤0.01%	3819
2021 Q2	$4K	Hold	25	–	–	﹤0.01%	3678
2021 Q1	$4K	Hold	25	–	–	﹤0.01%	3562
2020 Q4	$4K	Hold	25	–	–	﹤0.01%	3460
2020 Q3	$4K	Buy	+25	New	+$3.85K	﹤0.01%	3367
2019 Q1	–	Sell	-3	Closed	–	–	3636
2018 Q4	$0	Sell	3 -3	-50%	-$598	﹤0.01%	3681
2018 Q3	$1K	Buy	+6	New	+$2.18K	﹤0.01%	3581

Other funds holding SNOA

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

MCWS

McKinley Carter Wealth Services Wheeling, West Virginia $1.94B AUM 20.7% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

GRP

Global Retirement Partners San Rafael, California $6.54B AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

US Bancorp's SNOA Position: Q2 2026 in Review

US Bancorp sold out of Sonoma Pharmaceuticals (SNOA) in Q2 2026, closing a stake of 25 shares — an estimated $53 sold.

US Bancorp first reported a position in SNOA in Q3 2018 and held it in 25 quarters. The position peaked at $4K in Q2 2021. 14 funds tracked by Wall St. Rank hold SNOA as of Q2 2026.

US Bancorp reported no remaining Sonoma Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
US Bancorp sold 25 Sonoma Pharmaceuticals shares in Q2 2026, an estimated $53.
US Bancorp first reported a position in Sonoma Pharmaceuticals in Q3 2018 and held it in 25 quarters.
US Bancorp's Sonoma Pharmaceuticals position peaked at $4K in Q2 2021.
14 funds tracked by Wall St. Rank held Sonoma Pharmaceuticals as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.